Rödel CM - Search Results

1

Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2).

Merten R, Ott O, Haderlein M, Bertz S, Hartmann A, Wullich B, Keck B, Kühn R, Rödel CM, Weiss C, Gall C, Uter W, Fietkau R. Merten R, et al. Among authors: rodel cm. Oncologist. 2019 Dec;24(12):e1341-e1350. doi: 10.1634/theoncologist.2018-0280. Epub 2019 Jul 10. Oncologist. 2019. PMID: 31292267 Free PMC article.

2

Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia.

Wittlinger M, Rödel CM, Weiss C, Krause SF, Kühn R, Fietkau R, Sauer R, Ott OJ. Wittlinger M, et al. Among authors: rodel cm. Radiother Oncol. 2009 Nov;93(2):358-63. doi: 10.1016/j.radonc.2009.09.018. Radiother Oncol. 2009. PMID: 19837472

3

Radiochemotherapy for bladder cancer.

Ott OJ, Rödel C, Weiss C, Wittlinger M, St Krause F, Dunst J, Fietkau R, Sauer R. Ott OJ, et al. Clin Oncol (R Coll Radiol). 2009 Sep;21(7):557-65. doi: 10.1016/j.clon.2009.05.005. Epub 2009 Jun 28. Clin Oncol (R Coll Radiol). 2009. PMID: 19564101 Review.

4

Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients.

Keck B, Wach S, Taubert H, Zeiler S, Ott OJ, Kunath F, Hartmann A, Bertz S, Weiss C, Hönscheid P, Schellenburg S, Rödel C, Baretton GB, Sauer R, Fietkau R, Wullich B, Krause FS, Datta K, Muders MH. Keck B, et al. Int J Cancer. 2015 Jan 15;136(2):443-51. doi: 10.1002/ijc.28987. Epub 2014 Jun 12. Int J Cancer. 2015. PMID: 24862180 Free article.

5

[Radiochemotherapeutic options for bladder cancer].

Weiss C, Sauer R, Rödel C. Weiss C, et al. Aktuelle Urol. 2008 Mar;39(2):123-9. doi: 10.1055/s-2008-1038150. Aktuelle Urol. 2008. PMID: 18379965 Review. German.

6

Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy.

Bertz S, Wach S, Taubert H, Merten R, Krause FS, Schick S, Ott OJ, Weigert E, Dworak O, Rödel C, Fietkau R, Wullich B, Keck B, Hartmann A. Bertz S, et al. Virchows Arch. 2016 Sep;469(3):339-44. doi: 10.1007/s00428-016-1986-x. Epub 2016 Jul 8. Virchows Arch. 2016. PMID: 27392930

7

[Radiochemotherapy for invasive bladder cancer : An update].

Tselis N, Prott FJ, Ott O, Weiss C, Rödel C. Tselis N, et al. Urologe A. 2018 Jun;57(6):679-685. doi: 10.1007/s00120-018-0628-0. Urologe A. 2018. PMID: 29651707 Review. German.

8

Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.

Rödel C, Grabenbauer GG, Matzel KE, Schick C, Fietkau R, Papadopoulos T, Martus P, Hohenberger W, Sauer R. Rödel C, et al. Dis Colon Rectum. 2000 Mar;43(3):312-9. doi: 10.1007/BF02258294. Dis Colon Rectum. 2000. PMID: 10733111

9

Radiotherapy is an effective treatment for high-risk T1-bladder cancer.

Rödel C, Dunst J, Grabenbauer GG, Kühn R, Papadopoulos T, Schrott KM, Sauer R. Rödel C, et al. Strahlenther Onkol. 2001 Feb;177(2):82-8; discussion 89. doi: 10.1007/pl00002387. Strahlenther Onkol. 2001. PMID: 11233839

10

Individualized magnetic resonance imaging-based neoadjuvant chemoradiation for middle and lower rectal carcinoma.

Hermanek P, Hohenberger W, Fietkau R, Rödel C. Hermanek P, et al. Colorectal Dis. 2011 Jan;13(1):39-47. doi: 10.1111/j.1463-1318.2009.02076.x. Colorectal Dis. 2011. PMID: 19863611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page